Cost-benefit of rituximab for rheumatoid arthritis patients in Argentina

被引：0

作者：

Sole, J. P. ^{[1
]}

Ortega, G. P. ^{[1
]}

Kielhorn, A. ^{[2
]}

机构：

[1] Productos Roche SAQe I, Buenos Aires, DF, Argentina

[2] Hoffmann La Roche Ag, CH-4002 Basel, Switzerland

来源：

关键词：

D O I：

10.1016/S1098-3015(10)64918-2

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A243 / A244

页数：2

共 50 条

[31] COST-BENEFIT OF RADIOASTRONOMY
BURKE, BF
PHYSICS TODAY, 1979, 32 (06) : 15 - 15
[32] A cost-benefit state
McGarity, TO
ADMINISTRATIVE LAW REVIEW, 1998, 50 (01) : 7 - 79
[33] COST-BENEFIT OF PREVENTION
Chapman, David
CHEMICAL & ENGINEERING NEWS, 2012, 90 (02) : 2 - 2
[34] COST-BENEFIT APPROACH
WILLIAMS, A
BRITISH MEDICAL BULLETIN, 1974, 30 (03) : 252 - 256
[35] COST-BENEFIT EVALUATION
CLARK, DC
OLSEN, JB
JOURNAL OF RESEARCH AND DEVELOPMENT IN EDUCATION, 1977, 10 (03): : 64 - 78
[36] Recommendations on the use of rituximab for patients with rheumatoid arthritis
Rubbert-Roth, A.
Burmester, G.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2008, 67 (07): : 609 - 613
[37] Rituximab therapy in Greek patients with rheumatoid arthritis
Tsiakalos, Aristotelis P.
Avgoustidis, Nestor K.
Moutsopoulos, Haralampos M.
BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 911 - 916
[38] Rituximab therapy in patients with resistant rheumatoid arthritis
Masding, A.
Jois, R. N.
Somerville, M.
Gaffney, K.
Scott, D. G. I.
RHEUMATOLOGY, 2007, 46 : I27 - I27
[39] Lessons for rituximab therapy in patients with rheumatoid arthritis
Garcia-Montoya, Leticia
Villota-Eraso, Catalina
Yusof, Md Yuzaiful Md
Vital, Edward M.
Emery, Paul
LANCET RHEUMATOLOGY, 2020, 2 (08): : E497 - E509
[40] Recommendations for use of rituximab in patients with rheumatoid arthritis
Rubbert-Roth, A.
Burmester, G. R.
Doerner, T.
Gause, A.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 165 - +